# Adjuvant Capital

Investor in New York, New York

## About Adjuvant Capital

Adjuvant is a new type of venture capital firm. We invest in the most promising life science technologies for high-burden public health challenges.

We see enormous opportunities in historically overlooked market segments, and we leverage our unique expertise to translate these opportunities into social and financial returns for our investors.

Adjuvant Capital is a life sciences investment firm focused on global health. We make $10-$25 million investments in ambitious companies targeting opportunities in high burden and neglected disease.

Our mission is simple: use venture capital strategies to deploy capital in the most promising public health technologies and ensure they are made accessible to those who need them most.

We invest in innovative technologies to address high-burden and neglected infectious diseases, maternal and child health, nutrition, and reproductive and sexual health.

## People

- **Glenn Rockman**, Founder & Managing Partner

## Key Facts

- **Location:** New York, New York
- **Investor Type:** Venture Capital
- **Founded:** 2018

## Investment Industries

- Biotech
- Health and Wellness

## How to Contact

Direct messaging, this investor's website, and their LinkedIn profile are available with a paid Ask For Funding plan.

- [See plans and pricing](https://askforfunding.com/pricing)
- Already on a paid plan? [Log in](https://askforfunding.com/users/sign_in)

## More on Ask For Funding

- Full profile: https://askforfunding.com/investor/adjuvant-capital
- More investors: [Biotech Investors in New York](https://askforfunding.com/site/angel-investors/new-york/biotech)
- Find more investors: https://askforfunding.com/search/investors

Ask For Funding (AskForFunding.com) connects entrepreneurs with angel investors, private investors and venture capital firms in the United States, Canada and Australia.
